Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grever

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Selective Cancer Therapeutics|January 1, 1990
Phase I trial and biochemical evaluation of tiazofurin administered on a weekly scheduleT J Melink, G Sarosy, A R Hanauske, et al.
Leukemia|March 1, 1993
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group studyL Elias, D Stock-Novack, D R Head, et al.
Cancer Treatment Reports|December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group StudyR B Livingston, S Schulman, J G Mira, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemiaM R Grever, K J Kopecky, C A Coltman, et al.
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
American Journal of Clinical Oncology|February 1, 1992
Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group studyD H Ryan, K J Kopecky, D Head, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemiaB D Cheson, P A Cassileth, D R Head, et al.
Science (New York, N.Y.)|October 16, 1992
Neural computing in cancer drug development: predicting mechanism of actionJ N Weinstein, K W Kohn, M R Grever, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Selective Cancer Therapeutics|January 1, 1990
Phase I trial and biochemical evaluation of tiazofurin administered on a weekly scheduleT J Melink, G Sarosy, A R Hanauske, et al.
Leukemia|March 1, 1993
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group studyL Elias, D Stock-Novack, D R Head, et al.
Cancer Treatment Reports|December 1, 1986
Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group StudyR B Livingston, S Schulman, J G Mira, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemiaM R Grever, K J Kopecky, C A Coltman, et al.
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
American Journal of Clinical Oncology|February 1, 1992
Analysis of treatment failure in acute nonlymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group studyD H Ryan, K J Kopecky, D Head, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemiaB D Cheson, P A Cassileth, D R Head, et al.
Science (New York, N.Y.)|October 16, 1992
Neural computing in cancer drug development: predicting mechanism of actionJ N Weinstein, K W Kohn, M R Grever, et al.
Pageof 10